NL-OMON55414招募中不适用
Immunotyping lymph nodes in immune-mediated inflammatory diseases (IMIDs): lymph node cellular and molecular biomarkers in IMIDs - Immunotyping lymph nodes in immune-mediated inflammatory diseases (IMIDs)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •IMID patients
- •patients at risk of developing IMID
- •first degree relatives of IMID patients
- •healthy controls
排除标准
- •patients unable to give informed consent
研究者
相似试验
招募中
不适用
Detailed immunotyping of immune-mediated inflammatory diseases (IMIDs) by investigating cellular and molecular biomarkers in blood and synovial fluidNL-OMON55821Academisch Medisch Centrum700
招募中
不适用
Characterization of Inflammatory Cell Subpopulations of Gut Associated Lymphoid Tissue and Peripheral Lymph Nodes in Inflammatory Bowel DiseaseNL-OMON27715Academic Medical Center64
招募中
不适用
Detection of markers for immune pathophysiology and analysis of their prognostic value in patients with chronic thrombocytopenia without an increase in the number of bone marrow megakaryocytes: a prospective observation study.Pancytopenia, thrombocytopeniaJPRN-UMIN000002729Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science.50
尚未招募
不适用
Immune Function of Colorectal Cancer Lymph NodesLymph NodeColorectal CancerNCT06319404Shanxi Province Cancer Hospital500
已完成
不适用
Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.COVID-19NCT05951920Assistance Publique - Hôpitaux de Paris12